About the journal
The aim of the journal is to present Central European and international scientific achievements in pharmaceutical sciences. ... |
Editor-in-chief
All volumes and issues in this journal
Journal details
For reviewers
The European Pharmaceutical Journal (formerly Acta Facultatis Pharmaceuticae Universitatis Comenianae) is a peer-reviewed scientific journal with more than 50 years of publishing history, dedicated to advancing pharmaceutical sciences and supporting the development of young and emerging researchers.
Peer review is central to maintaining the quality, integrity, and credibility of scientific publishing. The Journal deeply values the time, expertise, and commitment of its reviewers, whose constructive evaluations contribute directly to improving published research and supporting scientific progress.
The Journal follows internationally recognized best practices in publication ethics, including the principles of the Committee on Publication Ethics (COPE).
1. Role of Reviewers
Reviewers play a critical role in ensuring the scientific quality, validity, and relevance of manuscripts submitted to the Journal. By accepting a review invitation, reviewers agree to provide an independent, objective, and timely evaluation based on their expertise.
Reviewers should only accept assignments for manuscripts within their area of competence and when they are able to complete the review within the requested timeframe.
2. Peer Review Process
The Journal operates a double-blind peer review system, in which the identities of both authors and reviewers remain concealed throughout the review process.
Each manuscript is typically evaluated by at least two independent expert reviewers.
Reviewers initially receive only the manuscript title and abstract to determine suitability and availability. Upon acceptance, full manuscript access is granted.
Reviewer identities remain confidential throughout and after the review process.
3. Reviewer Responsibilities
Reviewers are expected to:
Provide objective, constructive, and evidence-based evaluations Assess originality, scientific quality, methodology, and relevance Identify strengths and weaknesses of the manuscript Support critiques with clear reasoning and, where appropriate, references Distinguish between major and minor concerns Ensure recommendations align with the content of the review report Maintain confidentiality at all times
Reviews should be written in a professional tone and be suitable for communication to authors without substantial modification.
4. Confidentiality
All submitted manuscripts and associated materials are confidential documents. Reviewers must not:
Share or discuss manuscripts with others without editorial permission Use manuscript content for personal, academic, or commercial advantage Retain or distribute unpublished material outside the peer review process
Confidentiality obligations apply to all versions of the manuscript, supplementary materials, correspondence, and review reports.
5. Use of Artificial Intelligence Tools
Peer review requires independent expert judgment, critical thinking, and accountability. For this reason:
Reviewers must not use generative artificial intelligence (genAI) tools to generate, draft, or substantially assist peer review reports Manuscripts and related materials must not be uploaded to public or third-party AI platforms AI tools must not be used in any way that compromises confidentiality or intellectual property
Reviewers remain fully responsible and accountable for the content, accuracy, and integrity of their reviews.
6. Conflicts of Interest
Reviewers must disclose any actual, potential, or perceived conflicts of interest that could affect impartiality. These may include:
Financial or commercial interests Academic competition or collaboration Intellectual or ideological considerations
If a conflict exists or emerges during review, the reviewer should inform the Editor immediately.
7. Ethical Considerations and Misconduct
Reviewers should alert the Editor to any concerns regarding research integrity or publication ethics, including:
Plagiarism or redundant publication Data fabrication or falsification Image manipulation Ethical issues involving human or animal research Inappropriate authorship practices Undisclosed conflicts of interest Suspected undisclosed use of generative AI in manuscript preparation
Reviewers should not conduct independent investigations.
8. Preparing a Review
Reviews should be:
Clear, structured, and constructive Supported by scientific reasoning or evidence Focused on the manuscript’s content, not the authors personally
Reviewers are encouraged to:
Provide specific comments for improvement Identify missing analyses or insufficient evidence Suggest relevant literature when appropriate Comment on clarity, structure, and scientific presentation Separate major concerns from minor revisions
Recommendations (accept, revise, reject) must be consistent with the written comments.
Rejection decisions should generally be based on substantial scientific or methodological weaknesses rather than language, formatting, or minor technical issues.
9. Timeliness and Communication
Reviewers are expected to respond promptly to invitations, whether accepting or declining.
Once a review is accepted, it should be completed within the agreed timeframe.
If circumstances prevent timely completion, the Journal should be informed as soon as possible.
If new information arises after submission of a review that may affect the assessment, the reviewer should notify the Editor promptly.
10. Partial Reviews
If a reviewer evaluates only specific parts of a manuscript, this should be clearly indicated in the review report.
11. Revised Manuscripts
Reviewers are encouraged, where possible, to evaluate revised or resubmitted versions of manuscripts they have previously reviewed, to ensure continuity and consistency in the evaluation process.
12. Editorial Transparency
In exceptional cases, an Editor may contribute a review when additional expertise is required or when external reviewers are unavailable. Such contributions must be clearly identified as editorial input and must never be presented as anonymous external peer review.
13. Appreciation
|
The European Pharmaceutical Journal sincerely thanks its reviewers for their essential contribution to maintaining scientific quality, integrity, and progress in pharmaceutical sciences. Their expertise and commitment are vital to supporting both established and emerging researchers.